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A R T I C L E  I N F O   







Peripheral sheath tumors 
A B S T R A C T   
Exposure to N-nitroso compounds (NOCs) during pregnancy has been associated with an increase in brain tumors 
in the progeny. This study investigated the brain tumorigenic effect of N-ethyl N-nitrosourea (ENU) after dif-
ferential exposure of rats during pregnancy. 
Sprague Dawley rats were exposed to a single dose of ENU (80 mg/kg) in three different circumstances: 1) at 
first, second or third week of gestation; 2) at the 15th embryonic day (E15) in consecutive litters and 3) at E15 in 
three successive generations. Location and characterization of the offspring’s brain tumors were performed by 
magnetic resonance imaging and histopathological studies. Finally, tumor incidence and latency and the animals’ 
survival were recorded. 
ENU-exposure in the last two weeks of pregnancy induced intracranial tumors in over 70% of the offspring 
rats, these being mainly gliomas with some peripheral nerve sheath tumors (PNSTs). Tumors appeared in young 
adults; glioma-like small multifocal neoplasias converged on large glioblastomas in senescence and PNSTs in the 
sheath of the trigeminal nerve, extending to cover the brain convexity. ENU-exposure at E15 in subsequent 
pregnancies lead to an increase in glioma and PNST incidence. However, consecutive generational ENU-exposure 
(E15) decreased the animals’ survival due to an early onset of both types of tumors. Moreover, PNST presented 
an inheritable component because progeny, which were not themselves exposed to ENU but whose progenitors 
were, developed PNSTs. 
Our results suggest that repeated exposure to ENU later in pregnancy and in successive generations favours the 
development of intracranial gliomas and PNSTs in the offspring.   
1. Introduction 
The incidence of primary tumors in the central nervous system (CNS) 
in the United States was 21.97/100,000 persons in the period 
2008–2012 with a mortality rate of 4.31/100,000 (Ostrom et al., 2015). 
Gliomas are the most representative CNS tumors. They are associated 
with significant morbidity and mortality in adult populations. The 
etiology of primary brain tumors remains largely unknown, but their 
incidence increases with exposure to environmental pollutants or di-
etary intake. Among the factors governing disease susceptibility, there 
are some concerning habits, such as smoking or alcohol abuse; the 
environmental exposure to chemical carcinogens or radiation; biology, 
puberty, or ageing; or genetical inheritance of tumor suppressor muta-
tions or susceptibility alleles of modifier genes (Reilly, 2009; Mackenzie 
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and Harrison, 2016). 
Multiple epidemiological studies point to the exposure to chemical 
agents as an important factor for glioma development (Michaud et al., 
2009; Milne et al., 2013). More than 200 chemical compounds, acting as 
alkylating agents, have been described as neurotoxic substances for 
human beings. Some of them are associated with neurodevelopmental 
disabilities in children, including autism, dyslexia, and attention-deficit 
hyperactivity disorder (Grandjean and Landrigan, 2006, 2014). These 
include N-nitroso compounds (NOCs), which are among the simplest 
chemical carcinogens. NOCs are divided into two major groups: N- 
nitrosamides and N-nitrosamines, which are formed by the reaction of 
amides and amines, respectively, with nitrosating agents derived from 
nitrites. Moreover, NOCs can be endogenously formed by intake of ni-
trite and nitrate (Dubrow et al., 2010). In fact, some cancers such as 
colorectal, bladder and breast cancer have been associated with nitrate 
ingestion in drinking water (Ward et al., 2018). Food treated with ni-
trites for colouring, flavouring and preservation contain NOCs (Bielecka 
and Markiewicz-Żukowska, 2020). It is known that processed fish and 
meat products, such as bacon, sausages, and salami, have elevated levels 
of NOCs or precursors to their endogenous formation (Dietrich et al., 
2005). In addition, NOCs have been detected in tobacco smoke, in the air 
near rubber manufacturing plants, and in some cleaners and pesticides 
(Haorah et al., 2001; Braganza et al., 2014). Exposure to pesticides early 
in life has been related with the risk of CNS tumor development in 
observational epidemiological studies (Patel et al., 2020). Animal 
research has also demonstrated that NOCs are potent neurocarcinogens, 
especially via transplacental or perinatal exposure (Pogoda et al., 2009). 
Many of the NOC-induced experimental tumors are similar to analogous 
human tumors, a fact that makes us wonder if some human tumors could 
be caused by exposure to NOCs (Lijinsky, 1999). 
N-ethyl-N-nitrosourea (ENU) is a carcinogenic and teratogenic NOC 
that induces tumors and congenital abnormalities, especially in the CNS 
(Hallas and Das, 1978; Papathanasiou and Goodnow, 2005). This alky-
lating substance is a mutagenic compound widely used in the laboratory 
to generate murine tumor models. The first research trials with ENU 
showed that the highest incidence of CNS malignancies was obtained by 
intravenous injection of a dose between 40 and 80 mg/kg during the 
gestation period Martinez et al., 1974. Although administration of ENU 
to adult rodents did not induce tumors, transplacental administration in 
the last week of gestation (from E15 to E21) or during the first week 
(first 7 days, PN7, of postnatal development) induced tumors in more 
than half of the offspring (Jones et al., 1973; Slikker et al., 2004). On the 
other hand, intraperitoneal injection of a dose of 80 mg/kg of ENU to 
Sprague Dawley rats during pregnancy, specifically on the 15th day of 
gestation (embryonic day E15), induces the development of gliomas and 
schwannomas in offspring (Zook and Simmens, 2005; Koelsch et al., 
2013; Bulnes et al., 2018). ENU-induced tumors mimic the evolution 
and development of human brain tumors following a sporadic exposure 
to carcinogens, and neoplasms appear after several months of latency 
(Bulnes et al., 2012, 2018). Gliomas induced by transplacental exposure 
to ENU show histopathological characteristics of oligodendrogliomas 
containing exclusively NG2-expressing slow dividing precursor cells, 
which express early markers of oligodendroglial lineage (Briançon- 
Marjollet et al., 2010; Bulnes and Lafuente, 2007). ENU exposure also 
induces malignant schwannomas that arise predominantly in the tri-
geminal nerves. A point mutation of the neu/erbB-2 gene characteristic 
of ENU-induced rat schwannomas is an early marker of Schwann pre-
cursor cells at high risk of subsequent malignant transformation (Gering 
et al., 2006). The mechanism by which NOCs induce tumors is well 
understood. It is known that the amount of the dose, the frequency, and 
the route of administration to a certain species is determinant for tumor 
induction. These factors can change the affected organ and even the 
target cell from which the tumor develops. 
Hence, the aim of this study was to assess the tumorigenic effect of a 
NOC on the intracranial nervous tissue in the context of differential 
maternal exposure. For this purpose, we analyzed the incidence and 
latency of intracranial glioma and PNST development, as well as the 
survival time of offspring after exposing dams to ENU at different weeks 
of pregnancy, on the same day in consecutive pregnancies, and on the 
same day of pregnancy in successive generations. 
2. Materials and methods 
2.1. Animals 
Sprague-Dawley rats (300 g) were housed in groups of four animals 
under standard laboratory conditions (22 ± 1 ◦C, 55 ± 5% relative 
humidity, and 12:12 h light/dark cycle) with food and water provided 
ad libitum. Every effort was made to minimize animal suffering and to 
use the minimum number of animals per group and experiment. In this 
sense, following the principles of the 3Rs of animal wellness (Russell and 
Burch, 1959), in order to reduce the number of animals, we re-analyzed 
data from 55 animals belonging to previous assays, in which we applied 
the same methodology (Bulnes et al., 2009, 2010, 2012). From these 
three papers, we selected the material of 67 intra-axial gliomas induced 
in 55 rats. These rats were exposed to ENU at 15th prenatal day (E15) 
and sacrificed from 6th month to one year of age. The gliomas were 
segregated into 34 microtumors obtained from 27 rats and 33 macro-
tumors from 28 rats. In previous studies, in this same material we 
studied the microvascular network changes from low grade to high 
grade gliomas (Bulnes et al., 2009), we explored the immunoexpression 
of VEGF and eNOS, two molecules of vascular permeability (Bulnes 
et al., 2010) and identified a subpopulation of glioma stem like cells by 
two markers: nestin and CD133 (Bulnes et al., 2012). 
Experimental protocols were approved by the Local Ethical Com-
mittee for Animal Research of the University of the Basque Country 
(UPV/EHU, CEEA, ref. CEBA/82b/2010/LAFUENTESANCHEZ). All the 
experiments were conducted according to the European Community 
Council Directive on “The Protection of Animals Used for Scientific 
Purposes” (2010/63/EU) and with Spanish Law (RD 53/2013) for the 
care and use of laboratory animals. 
2.2. Experimental design 
In recent years, we have conducted several assays looking for cellular 
and molecular features of ENU-induced gliomas in Sprague Dawley rats 
(Bulnes et al., 2009, 2018). Rats were prenatally exposed to ENU, and 
subsequently, epidemiological data about tumor incidence and latency 
were recorded. The current study reports chronological data of intra-
cranial tumors development after ENU exposure protocols. 
2.2.1. Chronological tumor screening 
Rats were mated and the females checked daily for vaginal plugs to 
identify the embryonic day (E0). Ten dams were intraperitoneally 
injected with ENU (80 mg/kg, 10 mg/ml in 0.9% NaCl, Ref.: E2129, 
Sigma-Aldrich, Spain) at the 15th day of pregnancy (embryonic day 
E15). Their 108 offspring, 57 male and 51 female rats, were examined 
monthly using the “Health Status Assessment” (see section 2.3.) and MRI 
(see section 2.4), from 4th to 12th month of age to detect the presence of 
tumors. The animals were sacrificed monthly for the histopathological 
study. The number of rats sacrificed each month is reported in Table 2. 
2.2.2. Carcinogenic effects of differential ENU exposure 
Three groups were analyzed, depending on different ENU exposure 
protocols, as follows (Table 1): 
2.2.2.1. Group 1: pregnancy time. 116 offspring from 12 dams, intra-
peritoneally injected with ENU (80 mg/kg), were included in this assay. 
The offspring were segregated as follows: 5 offspring (1 male and 4 fe-
males) from two litters of 2 dams that received ENU during their first 
prenatal week (EW1); 23 rats (14 males and 9 females) from two litters 
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of 2 dams injected on the second prenatal week (EW2); and 88 rats (48 
males and 40 females) from eight litters of 8 dams that were exposed to 
ENU during their third prenatal week (EW3). The last 88 rats were 
further divided into two subgroups: 39 rats (18 males and 21 females) 
from four litters exposed to ENU at E15 and 49 rats (30 males and 19 
females) from four litters exposed at E20. 
2.2.2.2. Group 2: consecutive litters. Two dams were intraperitoneally 
injected in two consecutive pregnancies, both on the 15th embryonic 
day (E15). Finally, a total of 54 offspring rats from both litters: 29 rats 
(18 males and 11 females) from the first litter (L1) and 25 rats (16 males 
and 9 females) from the second litter (L2) were used for this study. 
2.2.2.3. Group 3: successive generations. Inherited tumorigenic effects of 
ENU were analyzed in two studies: 
A) ENU effects in offspring from three successive generations. 
Initially, three dams received ENU on the 15th day of their first preg-
nancy and 39 rats (20 males and 19 females) from F1 three litters were 
analyzed. Then, two males (F1) were mated with two female rats (F1). 
These females from F1 received ENU at E15. The resulting 22 rats (12 
males and 10 females) from F2 two litters were analyzed. Since males 
from F2 presented infertility (see Johnson et al., 1993; Yin et al., 2015), 
Three dams from F2 were mated with male control animals (Fig. 1A) and 
received ENU at E15. 10 rats (4 males and 6 females) from F3 three 
litters were finally analyzed. 
B) ENU effects in a second generation of offspring rats not exposed 
prenatally to ENU (F2*). Briefly, one control female, mated with a 
control male, was exposed to ENU on the 15th day of gestation. Then 
two females and two males from the first generation (F1), prenatally 
exposed to ENU, were mated but in this case the dams were not exposed 
to ENU during their gestation. Finally, the 23 offspring rats (11 males 
and 12 females) from F2 two litters not prenatally exposed to ENU were 
used in this study (Fig. 1B). 
2.3. Health status assessment 
Offspring were examined every two days from the 4th month to 
sacrifice in order to establish health status and to identify neurological 
Table 1 
Groups of Sprague Dawley rats used to study the brain tumorigenic effects of differential exposures to ENU.  
Group Time of exposure (embryonic day) Dams (n) Rats studied 
Total (n) Male (n) Female (n) 
Pregnancy 
time 
EW1 E3 2 5 1 4 
EW2 E8 2 23 14 9 
EW3 E15, E20 8 (4, 4) 88 (39, 49) 48(18/30) 40 (21/19) 
Consecutive litter L1 E15 2 29 18 11 
L2 E15 25 16 9 
Successive generation F1 E15 3 39 20 19 
F2 E15 2 22 12 10 
F3 E15 3 10 4 6 
F2* Not exposed 2 23 11 12 
E, embryonic day (prenatal day); EW, embryonic week (prenatal week); L1, first litter; L2, second litter; F1, first generation; F2, second generation; F2*, second 
generation rats not directly exposed to ENU, but are offspring of females prenatally exposed to ENU; F3, third generation. 
Fig. 1. Genealogical tree of Sprague Dawley rats used to study the inheritable tumorigenic effects of ENU. (A) Three generations of rats prenatally exposed to ENU. 
All dams were exposed to ENU on the 15th embryonic day (E15). (B) ENU inheritance effects studied in a second generation of offspring rats not directly exposed to 
ENU during pregnancy, but whose progenitors were prenatally exposed to ENU. P1, progenitor of the first generation; P2, progenitor of second generation; P3, progenitor of 
the third generation; F1, first generation; F2, second generation; F3, third generation. 
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deficits related to the presence of intracranial tumors. Health status was 
evaluated following the Morton-Griffiths inventory (Morton and Grif-
fiths, 1985) and, in addition, abnormal postures or vocalizations, un-
usual weight loss, extreme immobility or swollen eyes were recorded. 
Rats presenting deficits incompatible with life or achieving 15 or more 
points in the adapted Morton-Griffiths scale were sacrificed (Bulnes- 
Sesma et al., 2006, 2007). The tumor incidence, latency and survival of 
animals was recorded. 
2.4. ENU-induced intracranial tumor screening 
Screening of intracranial tumors was carried out in vivo by magnetic 
resonance imaging (MRI, Biospec BMT 47/40, Bruker, Ettlingen, Ger-
many, operating at 4.7 Tesla) using gadolinium contrast (1.5 ml/kg Gd- 
DTPA, Magnevist, Schering AG, Berlin, Germany), and by Evans Blue 
dye (EB, Sigma Aldrich, Spain, E2129, 28.5 mg/kg) at necropsy time. 
Intracranial tumors were segregated into intra and extra-axials tumors 
according to their location in the brain. After transcardial perfusion with 
4% fresh paraformaldehyde in 0.1 M PBS (pH 7.4), brains were 
removed, post-fixed overnight in the same solution, embedded in 
paraffin and processed for histological studies. Finally, histopathological 
diagnoses of these tumors were carried out by hematoxylin-eosin stain. 
Tissue slices were examined to record the presence of histological fea-
tures, such as cellular proliferation and anaplasia, atypical mitosis, 
microvascular proliferation, haemorrhages, necrosis, or cysts. 
2.5. Data analysis 
The effects of different exposures to ENU were analyzed by recording 
tumor incidence (TI), tumor latency (TL) and the overall survival time 
(OS) of rats. TI was calculated as the average number of rats (% of rats) 
that displayed tumors, and TL, the mean age (postnatal days, dpn) of 
tumor appearance. We performed a logistic regression analyses to assess 
whether the differential ENU exposure during the pregnancy was asso-
ciated with intracranial tumor development, while controlling for the 
effect of litter. Comparisons of TL between groups were performed using 
one-way ANOVA using litter as covariate. Finally, Kaplan-Meier analysis 
with censoring was used to plot survival probability, and survival curve 
differences between groups were assessed with log-rank test. Statistical 
analysis was performed using IBM SPSS software (IBM Statistics 24). 
Data was presented as group means ± standard error of the mean. The 
level of statistical significance was set at p < 0.05. 
3. Results 
Offspring from dams exposed to ENU developed intra and extra- 
cranial tumors affecting central as well as peripheral nervous system. 
At six months of age, some rats showed a change in behavior, becoming 
hyperactive or confused, walking in circles, running compulsively into 
objects, and looking dishevelled. Clinical signs such as head lateraliza-
tion, ataxic walk or anxiety were recorded. Symptomatology became 
severe with age. Four months later, they displayed numbness, apathy, 
seizures, and occasionally sudden death (Video 1). After necropsy, the 
rats showed intracranial tumors developed in the brain parenchyma or 
growth associated with the nerve sheath, mainly from the fifth cranial 
nerve. In addition, some animals showed paralysis of the lower ex-
tremities (Video 2) related to extra-cranial tumors growing inside the 
spinal cord or the nerve spinal sheath. 
3.1. Intracranial tumors after prenatal exposure to ENU at E15 
73.1% of offspring rats developed intracranial tumors. From a total 
of 57 male and 51 female rats, intracranial tumor incidence was similar 
between males (51%) and females (48%). Intracranial tumor prevalence 
increased from 40% at the 4th month and 90% at the 8th month to 100% 
after one year, affecting both the brain (intra-axial tumors) and the 
cranial nerve sheath (extra-axial tumors). Overall, 62% of rats devel-
oped intra-axial tumors and 26% extra-axial ones. The rate of intra-axial 
and extra-axial tumor development over time was similar between males 
and females (Table 2). 
Intra-axial tumors mainly located in parietal and occipital areas 
(Fig. 2) while extra-axial ones outside the brain were associated with the 
sheath of the trigeminal nerve (Fig. 3). Both types of tumors could be 
present at the same time in the same animal (Table 2). Incidence of intra- 
axial tumors was three-fold higher than that of extra-axial tumors. 
3.1.1. Lntra-axial tumors 
Intra-axial tumors (Fig. 2) started their growth as a proliferation of 
cells around the 4th month. At this time, 43% of the rats displayed 
proliferation of cells detected by microscopic examination in subcortical 
white matter near the subventricular zone (SVZ). These groups of cells 
became microtumors at the 6th month. MRI showed T2-w homogeneous 
hyperintense signals that corresponded to microtumors denoting small 
nodular shapes distributed in the cerebral cortex (Fig. 2A). At the 8th 
month of age, 83% of the rats studied displayed intra-axial tumors. 60% 
of these tumors were large enough to be considered as macrotumors 
(Table 2, Fig. 2A). Finally, 100% of one-year-old rats displayed intra- 
axial tumors that could infiltrate a whole hemisphere. Thus, the size 
of intra-axial tumors increased with the age of the rats. Indeed, there was 
a predominance of a single focus of intra-axial tumors with respect to 
multifocal locations. More than the 60% of the rats displayed a single 
focus (Fig. 2B, C). 
By histopathological study, microtumors were identified as classic 
oligodendrogliomas constituted by cells with rounded, homogeneous 
Table 2 
Chronological screening of intracranial tumors induced in Sprague Dawley rats after exposure of 80 mg/kg of ENU at E15.  
Time (month) Rats (n) 
(female/male) 
Tumor Incidence (% of rats) 
Total 
% (ratio female:male) 
Intra-axial Tumor 
% (ratio female:male) 
Extra-axial Tumor 
% (ratio female:male) 
Both Tumors %(ratio female:male) 
4 7 (1/6) 42.8 (− ) 42.8 (− ) 0 (− ) 0 (− ) 
5 7 (1/6) 57.1 (1:3) 42.8 (− ) 14.3 (− ) 0 (− ) 
6 29 (15/14) 72.4 (1.25:1) 41.4 (2.8: 1) 41.4 (1:1.5) 10.3 (1.8:1) 
7 15 (9/6) 73.3 (1:1.3) 66.7 (1.5:1) 46.7 (1:1.12) 40 (1:1.5) 
8 12 (4/8)) 91.7 (1.15:1) 83.3 (1.38:1) 33.3 (1:1.5) 25 (1:1) 
9 18 (10/8) 77.8 (1:1.25) 77.8 (1: 1.25) 11.1 (1:1.25) 11.1 (1:1.25) 
10 15 (9/6) 66.7 (1:1) 66.7 (1:1) 6,7 (− ) 6.7 (− ) 
12 5 (2/3) 100(1:1) 100 (1:1) 40 (− ) 40 (− ) 
Total 108 (51/57) 73.1 (1:1.03) 62 (1.08:1) 26 (1.12:1) 14.8 (1.4:1) 
Proportion (%) of rats displaying newly developed intracranial tumors (intra-axial and/or extra-axial tumors and/or both type of tumors) each month, from 4 to 12 
months of age. Tumor incidence is shown as the proportion of rats showing tumors each month, and the sex ratio is provided in parentheses. (− ) no ratio is calculated 
due to low number of affected rats. 
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nuclei, and clear cytoplasm (honeycomb pattern) (Fig. 2D). On the other 
hand, macrotumors showed polymorphous, anaplastic areas with 
marked cellular anaplasia, atypical mitosis, haemorrhagic areas, and 
microvascular hyperplasia (Fig. 2E). They were mainly diagnosed as 
anaplastic gliomas. However, the macrotumors, that showed endothelial 
proliferations, macrocysts and necrosis with pseudopalisading, were 
diagnosed as glioblastoma multiforme. Therefore, low grade gliomas 
were observed in rats from 6 to 7 months old, anaplastic gliomas at the 8 
Fig. 2. Intra-axial tumors developed after prenatal exposure to ENU at E15. (A) Single (a) and multifocal (b) tumors located on parietal and occipital areas shown on 
MRI (T1 sagittal section showing the head of the rat and T1, T2, coronal sections of the brain) and Evans blue staining. HE staining reveals (c) a small proliferative 
mass of cells in the subventricular zone (SVZ, arrow), (d) a tumor with a nodular shape, and (e) a large tumor occupying a hemisphere. (B, C) Graphs representing 
tumor location and size during rat development. Single macrotumors predominated in rats of advanced age. (D) Homogeneous pattern of round fusiform cells 
distributed adjacent to the subcortical white substance characteristic of proliferative cell masses of cells. (E) Macrotumor displaying cellular anaplasia, hyperplastic 
vessels and haemorrhagic areas. Scale bar of 200 μm (Ac, Ad, Ae) and scale bar of 50 μm (D, E). 
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month and glioblastomas at over one year of age. 
Almost half of the brains showed two or more gliomas with different 
degrees of malignancy. Due to their natural growth, two or more 
microgliomas converged and, after one year, there was predominantly a 
single, extensive highly malignant glioma. 
3.1.2. Extra-axial tumors 
Extra-axial tumors (Fig. 3) developed from the sheath of the tri-
geminal nerve. Affected rats showed neurological signs such as numb-
ness and seizures. MRI showed homogeneous strong gadolinium 
enhancement signals on the T1-w image. Due to their location, they 
could be segregated into basal tumors (BT) and convexity tumors (CT). 
Basal tumors grew out from the sheath of Gasserian ganglion, extending 
to invade and infiltrate both trigeminal nerves. Convexity tumors 
extended along the meninges covering the brain convexity, mainly in the 
frontal areas, occupying the subarachnoid space, and growing into the 
Virchow-Robin spaces (Fig. 3A). 
The highest incidence of extra-axial tumors was found between the 
6th and 7th months of age, corresponding with 40% and 50% of the rats 
studied. After the 7th month, their incidence decreased. This decrease 
might be related to basal tumor growth and subsequent pressure in the 
medulla oblongata, damaging the vital centers and resulting in animal 
death. Most of the animals that developed extra-axial tumors died at 7th 
month. This could be the cause of decreased incidence of intracranial 
tumors at 8th, 9th and 10th months (Fig. 3B). 
Basal tumors predominated over convexity ones. Their incidence was 
three-fold higher than convexity tumors (Fig. 3B). This could be related 
to a later development of convexity tumors than basal ones. 
According to the histopathological study, cellular pleomorphism, 
anaplasia and cellular atypia were characteristic of these tumors (Fig. 
3Ca). Extra-axial tumors located on the convexity showed elongated 
nuclei with brisk mitotic activity and tightly packed fasciculate growth. 
Sometimes, cells were associated with fasciculus interweaving in all 
directions. This fasciculate growth acquired eddy-shaped structures, 
which are characteristic of schwannomas (Fig. 3Cb). Considering these 
histopathologic features, extra-axial tumors were diagnosed as periph-
eral sheath nerve tumors (PNSTs), concretely as schwannomas and 
malignant peripheral nerve sheath tumors (MPNSTs). Schwannomas 
appeared one month earlier than gliomas, at the 5th month, and 
MPNSTs two months later than schwannomas. 
3.2. Tumorigenic effects of ENU after differential exposure of dams 
3.2.1. Pregnancy week of ENU-exposure: EW1, EW2 and EW3 
Regarding ENU-exposure at different time points, the data regarding 
the critical period for inducing intracranial results show that the expo-
sure of dams to 80 mg/kg of ENU at the initiation of the gestational 
period, during the first week of prenatal development (EW1), lead to the 
development of severe congenital malformations in the offspring. Most 
of these were incompatible with life (Fig. 4). However, exposure to ENU 
after the initial week of gestation, during the second (EW2) and third 
(EW3) week of prenatal development induced intracranial tumors in the 
offspring. The results show no differences between intracranial tumor 
incidence (TI), tumor latency and overall survival between rats from 
EW2 and EW3 (Fig. 5A) (Table 3-4). Nearly 70% of the rats from both 
groups developed intracranial tumors: 60% of them inside the brain and 
30% outside it (Table 3). Significant differences were observed for the 
incidence and the latency of the extra-axial tumors. A higher incidence 
of tumors was observed after ENU administration in EW3, but these 
tumors took one more month to develop (Table 3). 
Moreover, it has been reported that from E15 to E18 is the critical 
period for the induction of intracranial tumors in offspring caused by 
Fig. 3. ENU-induced extra-axial tumors associated with the Gasserian ganglion. A) Macroscopic images by MRI T1-w and Evans Blue dye reveal a growth pattern 
from the trigeminal nerve sheath covering the convexity throughout the meningeal sheaths. HE staining shows the two location of the tumors: (a) on the base of the 
brain and (b, c) on the convexity. Convexity tumor grows thorough the interhemispheric cleft (b), and Virchow Robin spaces (c). B) Bar chart showing the frequency 
of extra-axial tumor location by rat’s age. Basal location of the tumor predominates over the expansion into the convexity area. At 6 and 7 months, the two locations 
are affected at the same time. C) Basal tumor shows cell bodies of sensory neurons of trigeminal ganglion and plenty of hyperchromatic neoplastic cells anarchically 
distributed around them. Convexity tumor displays fusiform cellular pattern with mitotic cells and hyperchromatic spindle cells with abundant, faintly eosinophilic 
cytoplasm. Scale bar of 200 μm (A) and scale bar of 20 μm (C). 
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chemical exposure (Thomas et al., 1994). We evaluated the tumor 
incidence in E15 and E20-exposed rats and observed that the time of 
prenatal exposure affected the incidence of intra-axial and extra-axial 
tumors. The intra-axial incidence was higher in rats exposed at E20 
than at E15 (p < 0.05). However, the opposite was observed regarding 
the incidence of extra-axial tumor: the incidence was higher for rats 
exposed at E15 (p < 0.001). In addition, the data showed that exposure 
at E15 induced an earlier development of intracranial tumors compared 
to exposure at E20 (p < 0.01), being two months earlier for intra-axial 
and one month earlier for extra-axial tumors in E15 injected animals 
(p < 0.01). This time point also affected the survival of rats. Rats 
exposed to ENU at E15 showed a shorter survival time than E20 injected 
animals (two months less than the other groups, p < 0.01) (Table 5, 
Fig. 5A). 
3.2.2. Consecutive Litters ENU-exposure at E15 
Exposure to ENU during consecutive pregnancies of the same dam 
increased the intracranial tumor incidence and latency in the offspring. 
Briefly, the incidence of intra-axial as well as extra-axial tumors 
increased with the litter exposure. A significant difference was only 
found for extra-axial tumors (ETI = 34% from L1, and ETI = 64% from 
L2, p < 0.05). 
In addition, intra-axial tumors developed later after exposure to ENU 
in two consecutive litters. They were detected one month later in L2 than 
L1 (p < 0.05) (Table 3). The survival time of rats from both litters was 
not affected by the successive exposure of the dams to ENU. Rats dis-
playing intra- or extra-axial tumors survived the same time, around 7 
months (Table 4). Moreover, half of the rats affected by any tumor were 
able to survive for 200 days (Fig. 5B). 
3.2.3. Successive generation exposure to ENU at E15 
The major inherited effect due to successive generation prenatal 
exposure to ENU was sterility. Since most of the male rats from the second 
generation were sterile, new progenitors were used for mating, while the 
females’ reproductive capacity was drastically reduced. The number of 
offspring decreased from 11 to 13 in F1 to 6–8 in F3. In addition, tera-
togenic effects such as smaller brain size were observed (Fig. 4C). 
An increase of intracranial tumor incidence and a decrease of tumor 
latency were appreciated with generational exposure to ENU (F1-TI =
76% and F2-TI = 90% of rats, F1-TL = 8 months and F2-TL = 7 months). 
Statistical analyses showed that generational exposure to ENU favoured 
an earlier development of intracranial tumors, concretely, intra-axial 
tumors (TL, p < 0.001, Table 3). Extra-axial tumor development was 
favoured by generational exposure to ENU. Tumor incidence was eight 
times greater in the second generation, compared to the first one (F1- 
ETI = 7% to F2-ETI = 61%) and they appeared two months earlier in F2 
than in rats from F1 (F1-ETL = 9 months and F2-ETL = 7 months). 
However, we did not find statistically significant differences for extra- 
axial tumor incidence and latency after controlling for the effect of 
litters. 
Regarding survival of animals, F2 rats displaying extra-axial tumors 
survived three months less than F1 rats (p < 0.001, Table 4). Half of the 
animals from F2 only reached 7 months of age, while those from F1 
reached 9 months (Fig. 5C). 
It must be noted that the tumor latency and survival of the offspring 
belonging to a second generation not exposed prenatally to ENU (F2*) 
were not measured because these rats did not develop any neurological 
symptom or sign suggestive of intracranial tumors. However, the ani-
mals were sacrificed at month 12 (mean age of 382.2 ± 26.7 dpn), and 
we observed that 21.7% of rats showed proliferative cell masses in the 
cerebral cortex and in intraventricular area (mean age of 389.4 ± 24.5 
dpn). Small schwannomas associated with the Gasserian ganglion were 
also observed in the 30% of these rats (mean age of 383.4. ± 29.01 dpn). 
These offspring were not exposed prenatally to ENU, but their pro-
genitors were exposed during their prenatal time. This means that cur-
rent tumors were not induced by direct exposure to ENU during the 
Fig. 4. Developmental defects induced by different exposure 
to ENU. Early prenatal exposure to ENU in the first week of 
pregnancy induced craniofacial malformations such as: uni-
lateral anophthalmia in a female rat (A) and bilateral anoph-
thalmia in a male (B). Advanced generation prenatal exposure 
to the chemical generates neural defects. (C) Macroscopic 
photograph of two brains of rats prenatally exposed to ENU 
from the first generation (above) and from the third one 
(below). Brain from the third generation shows hypoplasia of 
the hemispheres and elongated brain stem.   
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Fig. 5. Kaplan Meier survival curves of rats exposed to a single dose of ENU at different timings: (A) in the last two weeks of gestation at E8, E15 and E20; (B) in two 
consecutive litters: L1, first litter; L2, second litter; and (C) in successive generations: F1, first generation; F2, second generation. 
Table 3 
Study of intracranial tumor incidence and latency of rats subjected to different exposures to ENU.  
















EW2 65.2  199.5 ± 14.02  56.5  208.1 ± 14.5  21.7  168.2 ± 15.1    
ns  ns  ns  ns  0.027  0.025 
EW3 73.8  216.8 ± 7.2  61.3  225.1 ± 8.1  28.4  204.4 ± 9.5                
Consecutive 
Litters 
L1 65.5  178.9 ± 8.7  48.8  179.1 ± 11.1  34.4  185.2 ± 9.4    
ns  0.02  ns  0.009  0.02  ns 
L2 88  208.3 ± 8.7  68  218.5 ± 9.6  64  193.2 ± 8.04                
Successive 
Generation 
F1 76.9  240.4 ± 12.3  76.9  240.4 ± 11.7  7.6  285.0 ± 28.5    
ns  <0.001  ns  <0.001  ns  ns 
F2 90.9  211.1 ± 14.9  72.7  221.2 ± 16.1  61.6  211.6 ± 13.2  
Intracranial tumor incidence of rats according to several experimental procedures. Differences of tumor incidence between groups were examined by logistic regression 
to test whether ENU-exposure was associated with tumor development, while controlling for the effect of litter. Tumor latency was analyzed with one-way ANOVA 
using litter as covariate. p-values <0.05 are considered significant; ns: non-significant. TI, tumor incidence, proportion of rats developing tumors; TL, tumor latency, 
mean postnatal days until the development of tumors. EW, embryonic week; L1, first litter; L2, second litter; F1, first generation; F2, second generation. 
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prenatal time, but by induced mutations transferred by the ENU-exposed 
progenitors. 
4. Discussion 
In this study, we have documented the relevance of successive 
exposure and generational prenatal exposure to the neurotoxic com-
pound ENU as two relevant circumstances in the development of 
intracranial tumors. Late or successive exposure to this alkylating agent 
during the gestational period leads to development of gliomas and 
PNSTs in the progeny. Glioma incidence was favoured by later prenatal 
exposure. Repeated generational exposure to ENU decreased the sur-
vival of rats due to an increased rate of PNSTs and early onset glioma 
development. 
4.1. Gestational time is relevant to the induction of gliomas and PNST 
after exposure to ENU 
There is little consensus about the tumorigenic capacity of some 
NOCs in primary CNS tumors. Maternal dietary exposure to NOCs during 
pregnancy has been associated with a risk of childhood brain tumors 
(Dietrich et al., 2005). Some animal studies have indicated that NOCs 
cross the placenta and affect the fetus in utero (Bruning-Fann and 
Kaneene, 1993). Indeed, the blood brain barrier (BBB) is incompletely 
developed in the prenatal period, and toxic agents can enter into the 
CNS, which is much more vulnerable to toxic agents than in the case of 
adults (Thomas et al., 1994). 
ENU is a carcinogenic and teratogenic substance that freely crosses 
the placental barrier and does not require any metabolic activation. Our 
results demonstrate that a single dose of ENU to dams in the first week of 
pregnancy, corresponding with the beginning of the first trimester of 
human development (Chen et al., 2017), when organogenesis begins, 
induces severe congenital malformations (microcephaly, hydrocephaly) 
in the progeny. Several epidemiologic studies have shown an association 
between maternal exposure to nitrite and nitrate substances in food and 
drinks and birth defects, including neural tube defects (NTDs) such as 
anencephaly and spina bifida (Andersen et al., 2000; Massa et al., 2020). 
Results also corroborate the teratogenic effects of ENU in the early 
murine craniofacial development (Thomas et al., 1994; Sandell et al., 
2011). 
On the other hand, a key aspect for evaluating the tumorigenic effect 
of exposure to any toxic substance is the age of the animal (Rice, 2006). 
This work demonstrates the carcinogenic potential of ENU-exposure 
during the last two weeks of the gestational period. Prenatal exposure 
to ENU (80 mg/kg) induces intracranial tumors, diagnosed as gliomas, 
schwannomas and MPNSTs, in nearly 70% of the progeny. It is known 
that ENU acts by alkylating O6-guanine, O2-thymine and O4-thymine 
(Justice et al., 1999). These mutations affect the expression of the on-
cogenes neu/erbB, Ha-ras, p53, and genes coding for caspase-9, platelet- 
derived growth factor receptor alpha (PDGFRa), cyclin-dependent ki-
nase inhibitor 2A (CDKN2A) and epidermal growth factor receptor 
(EGFR). The expression of neu/erbB2 is associated with development of 
schwannomas, and p53 with glial tumors (Thomas et al., 1994; Zook 
et al., 2000; Katayama et al., 2005; Mukherjee et al., 2006). Gil-Perotin 
et al. (2011) reported that after administering ENU late in the gesta-
tional period, the cell cycle was arrested in neuroepithelial cells of the 
subventricular zone (SVZ) and the ventricular zone (VZ) in a p53- 
dependent manner. These altered neuroepithelial cells generate glial 
lineage tumors such as oligodendroglioma, astrocytomas, mixed gli-
omas, and ependymomas (Mennel et al., 2004). In the current study, we 
determined that maternal exposure to ENU significantly favours the 
induction of gliomas comparable to schwannomas. These ENU-induced 
gliomas mimic the evolution and development of human gliomas after 
sporadic exposure to carcinogens, and neoplasm appears after several 
months of latency (Bulnes-Sesma et al., 2006; Bulnes et al., 2010; Bulnes 
et al., 2012; García-Blanco et al., 2016). It is common to find collections 
of isomorphic cells near the subventricular zone (SVZ). Then, some 
months later, the same cells form a small nodular low-grade glioma, 
typically diagnosed as oligodendroglioma, showing mild features of 
anaplasia. They usually involve subcortical white matter and the cortex. 
Tumors grow and converge into large tumors, becoming malignant and 
evolving into glioblastomas in older rats (around one year of age). 
Making a translational comparison between rat and human ages, the 
exposure to ENU at the end of the gestational period implies the 
development of primary brain tumors in young human adults (Quinn, 
2005). As proposed by Recht et al. (2009), offspring rats prenatally 
Table 4 
Study of survival time of rats subject to different exposures to ENU.   
Intracranial tumors  Intra-axial tumor Extra-axial tumor 
Prenatal 
time 
EW2 EW3 p  EW2 EW3 p EW2 EW3 p 
288.4 ± 33.9 227.8 ± 6.8 ns  304.2 ± 35.7 239.47 ± 7.05 ns 435 ± 37.2 272.0 ± 8.8 ns            
Consecutive litters L1 L2 p  L1 L2 p L1 L2 p 
190.6 ± 9.9 209.2 ± 8.5 ns  208.4 ± 14.2 221.6 ± 8.9 ns 211.1 ± 12.4 214.6 ± 9.4 ns            
Successive Generation F1 F2 p  F1 F2 p F1 F2 p 
248.1 ± 10.6 213.9 ± 10.5 0.004  248.1 ± 10.6 226.9 ± 10.1 0.034 317.3 ± 7.0 229.7 ± 13.1 <0.001 
Overall survival of animals separated by experimental groups. Data are reported as mean ± SEM. Group comparisons were performed using Log Rank test. Significant 
comparisons (p-value <0.05) are indicated with the corresponding p-value. ns, non-significant. EW, embryonic week; L1, first litter; L2, second litter; F1, first gen-
eration; F2, second generation. 
Table 5 
Study of tumorigenic effect of ENU-exposure at E15 and E20.   
Intracranial tumor Intra-axial tumors Extra-axial tumors 
E15 E20 p E15 E20 p E15 E20 p 
Tumor incidence 69.2 77.5 ns 53.8 67.3 0.024 30.8 26.5 <0.001 
Tumor latency 180.2 ± 8.2 242.8 ± 8.7 <0.01 179.1 ± 9.8 254.3 ± 8.37 0.001 189.9 ± 8.12 217.0 ± 16.2 <0.01 
Overall survival time 194.1 ± 8.9. 249.9 ± 8.1 <0.001 204.9 ± 10.6 260.9 ± 7.44 <0.001 225.5 ± 11.3 288.6 ± 9.8 0.003 
Overall survival time and tumor latency are expressed by mean postnatal day ± SEM. Tumor incidence is expressed as the proportion (%) of rats that developed 
intracranial tumors. Differences in tumor incidence were examined using logistic regression to test whether the timing of ENU exposure was associated with tumor 
development, while controlling for the effect of litter. Tumor latency was analyzed with one-way ANOVA using litter as covariate. Significant comparisons (p-value 
<0.05) are indicated with the corresponding p-value. ns, non-significant. E, embryonic day (prenatal day). 
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exposed to ENU show a clinical situation analogous to that of young 
patients who develop brain tumors several years after receiving 
chemotherapy. 
Many metabolism-dependent carcinogens are toxic to the fetal rat 
only when given to the dam at the very end of gestation, when fetal 
metabolic competence has presumably evolved to the stage that the 
carcinogen can be biotransformed by fetal tissues (Rice et al. 2006). In 
this work, we compare the ENU neurocarcinogenic effect in fetal rats 
from the last two weeks of gestation (E7-E14 and E15-E21, respectively), 
finding similar tumor incidence and latency. Rice et al. (2006) described 
how the rat fetus at E15 is at least 50 times more susceptible than adults 
and that well-tolerated single doses of ENU can cause multiple primary 
brain tumors in 100% of exposed offspring. In this study, we investi-
gated the effect of this chemical in rat fetuses at E15 compared to E20. 
Our results show that E15 rats survived significantly less time than E20 
rats, due to an earlier onset of gliomas. Moreover, comparing E15 fetal 
rats and early live rats (7 postnatal day, PN7) exposed to ENU, a 
significantly later development of gliomas in neonatal rats compared to 
prenatal ones was observed (data not published). Some experiments 
have demonstrated that fetus brains are less able to efficiently excise or 
repair the DNA alkylation induced by mutagenic agents than postnatal 
brains (Shrivastav et al., 2010). Mullerd and Rajewsky, in 1983, re-
ported the relationship between prenatal day 15 and the expression and 
subsequent switch-off of the 06-EthylGuanine-eliminating enzyme(s) in 
the embryonic brain. This finding shows the importance of the 15th day 
of prenatal development of murine animals in the induction of gliomas. 
This time corresponds with the beginning of the third trimester of 
human gestation (Workman et al., 2013; Bolon and Ward, 2015). 
4.2. Glioma and PNST development favoured by successive exposure of 
dams to ENU 
Because the tumorigenesis process requires the accumulation of 
multiple mutations in cells, another purpose of this study was to assess 
the effect in the offspring of successive maternal exposure to ENU. 
Several ENU-exposures of the same dam during consecutive pregnancies 
favour the development of glioma and PNST. The glioma-induction in-
creases in the consecutive litters, but their time of appearance in the 
cerebral parenchyma is delayed. It has been reported that repetitive 
administration of N-methyl-N nitrosourea implies an accumulation of 
O6-methylguanine in the rat brain (Margison and Kleihues, 1975). 
4.3. Generational exposure to ENU during gestation favours PNST 
induction 
Several tumors of the nervous system are associated with familial 
cancer predisposition syndromes. These include Li- Fraumeni syndrome, 
tuberous sclerosis and Turcot syndrome and neurofibromatosis (Fre-
bourg et al., 2020; Malbari and Lindsay, 2020; Strowd, 2020). It has 
been reported that mutations of the type 1 Neurofibromatosis (NF1) gen 
and the type 2 Neurofibromatosis (NF2) gen are associated with sheath 
tumors (Jenkins et al., 2010; Chapman et al., 2015). Our results showed 
the inherited tumorigenic effect of exposure to ENU of the peripheral 
nervous system of prenatal animals. We found PNSTs in young rats not 
prenatally exposed directly to ENU but born from mothers exposed to it. 
Moreover, prenatal ENU exposure in consecutive generations mainly 
favoured the incidence and latency of schwannomas/MPNSTs. In line 
with this, a finding that must be noted is that offspring rats develop 
tumors without having been exposed to the toxin while their progenitors 
have. This could be explained because ENU is one of the most potent 
mutagens in murine germ cells, especially in stem-cell spermatogonia, 
by Stx2/Epim gene mutation and haemoglobin loci mutation (Murota, 
1995; Akiyama et al., 2008). Thus, ENU prenatal exposure induces 
mutations in the germ cells that are transferred to the offspring. 
The development of MPNSTs may be influenced by NF1, an illness 
caused by the inheritance of a defective allele of the NF1 gene. On the 
other hand, there is a close association of NF2 mutations in schwannoma 
with loss of merlin expression (the NF2 gene product) (Louis et al., 
2016). NF1 is among other hereditary syndromes associated with a ge-
netic predisposition to nervous system tumors (Wrensc et al., 2002; 
Bondy et al., 2008). The NebB2 gene, altered by prenatal exposure to 
ENU, may be an inherited gene with a strong influence on the risk of 
developing MPNSTs, and a person who was prenatally exposed to ENU 
might have a genetic predisposition to developing neurofibromatosis. 
Therefore, children of parents who are carriers of defective alleles of 
tumor-associated genes would be at risk for the familial cancer 
syndrome. 
5. Conclusion 
In conclusion, the fetal CNS is highly susceptible to the genotoxicity 
of ENU, resulting in brain abnormalities and tumors. Our data confirm 
that maternal exposure to ENU during successive generations and sub-
sequent pregnancies could contribute to the development of glioma and 
PNSTs in the offspring. Moreover, progenitors exposed to ENU transmit 
to their germ cells the mutation necessary for the development of PNSTs 
in their offspring. 
Therefore, one of the causes of the increase in brain tumor incidence 
in the last few decades might be the generational exposure to N-nitroso 
compounds during the third trimester of gestation. Moreover, not only 
direct prenatal exposure but also prenatal progenitor’s exposure could 
be considered as a risk of brain tumors development. 
One of the routes of exposure to these chemicals in pregnant women 
is their diet. Dietary factors that could significantly increase brain tumor 
development are still not clearly identified and described (Bielecka and 
Markiewicz-Żukowska, 2020). It is known that processed meat products, 
such as bacon, sausages, and salami, have elevated levels of NOCs or 
precursors for their endogenous formation (Dietrich et al., 2005). Thus, 
as diet is a potentially modifiable behavior, studying the association 
between NOC intake from foods and drinks and brain tumor develop-
ment might result in an important disease prevention strategy. 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.ntt.2021.106998. 
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